Suboxone Tooth Decay Litigation: 2026 Predictions

Plaintiffs claim that prolonged exposure to Suboxone led to rapid dental deterioration and required extensive dental work, including tooth extractions. The MDL, overseen by Judge J. Philip Calabrese in Ohio, is based on claims that Suboxone’s manufacturers failed to adequately warn patients and prescribers about dental risks associated with the drug’s delivery method, i.e., its acidic oral film. Court orders require plaintiffs to submit detailed use and injury through medical and dental records, a process designed to separate substantiated injury claims from those lacking documentation.

Meanwhile, defendants Indivior and Reckitt Benckiser challenge causation, severity, and liability as the litigation moves closer to discovery its first trial selection. Legal experts say the Suboxone litigation has begun an enforcement-heavy phase focused on record collection, compliance, and case vetting—steps that are critical to determining whether the MDL advances toward trials or contracts under dismissals.

Census Shakeout

2026 is expected to bring fights about what counts as adequate proof and what gets dismissed. According to a court order filed in October 2025, the court requires clean plaintiff fact sheets/census forms and usable records; The June 1, 2026 census deadline is basically a shakeout and setting the stage for dismissals, bellwethers, and mounting settlement pressure. Suboxone attorneys expect the census deadline may decide which Suboxone claims survive and which are dismissed outright. By narrowing the case pool, litigation should be pushed to its first bellwether phase by the end of 2026.

Bellwether Plan

With record collection underway, 2026 is expected to transition from bellwether planning to bellwether execution, once the court has completed record collection and census requirements. According to case management orders, the court has ordered a 500-plaintiff record pool drawn from both individually filed cases and group filings. And a threshold has been set: once records are obtained for at least 85% of the pool, the parties are required to jointly propose a schedule for the next phase of the litigation.

A Core Discovery Pool is the next phase: a smaller group of plaintiffs will undergo focused discovery designed to test causation, injury severity, and factual defenses. From there, the court is expected to narrow the cases further into a Trial Selection Pool for potential bellwether trials. Legal observers say this structure reflects the court’s intent to avoid premature trial dates and instead force the parties to build a vetted, representative set of cases before proceeding.

Settlement Status

Currently, no global settlement has been reached in the Suboxone tooth-decay litigation (MDL 3092). Because plaintiffs and defendants are still in the pretrial phase, no settlement checks have been issued and all compensation figures being discussed publicly are projections and estimates. Several law firms offer projections for future settlements once/if a global resolution is reached:

• From about $25,000 to $150,000 per claim, depending on severity of injuries and documented damages.
• Broader projections in the mass-tort press extend a further range: $10,000 to $500,000 and more in particularly severe dental injury cases.
• One firm suggests individual payouts could reach higher if dental damage is extensive, with a few even noting the possibility of figures above $150,000

Lawyers familiar with the MDL say that mid-to-late 2026 could be the first realistic period when global settlement discussions pick up, and they will be tied to bellwether progress.